BDBM50334039 (S)-3-methyl-4-(3-(4-(3-(trifluoromethyl)phenyl)-1H-imidazol-2-yl)benzyl)morpholine::CHEMBL1644678
SMILES: C[C@H]1COCCN1Cc1cccc(c1)-c1nc(c[nH]1)-c1cccc(c1)C(F)(F)F
InChI Key: InChIKey=HWCMNGZGIQKDGG-HNNXBMFYSA-N
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM50334039 ((S)-3-methyl-4-(3-(4-(3-(trifluoromethyl)phenyl)-1...) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 169 | n/a | n/a | n/a | n/a |
Merck Research Laboratory Curated by ChEMBL | Assay Description Agonist activity at human cloned CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation | Bioorg Med Chem Lett 21: 182-5 (2010) Article DOI: 10.1016/j.bmcl.2010.11.044 BindingDB Entry DOI: 10.7270/Q20P108G | |||||||||||
More data for this Ligand-Target Pair |